Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKesson
Boehringer Ingelheim
Moodys
AstraZeneca

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Nitrazepam

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Nitrazepam?

Nitrazepam is an investigational drug.

There have been 4 clinical trials for Nitrazepam. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2015.

The most common disease conditions in clinical trials are Epilepsy, Anxiety Disorders, and Sleep Initiation and Maintenance Disorders. The leading clinical trial sponsors are National Institute for Health Research, United Kingdom, Birmingham Children's Hospital NHS Foundation Trust, and Matthew's Friends.

There is one US patent protecting this investigational drug and fifteen international patents.

Recent Clinical Trials for Nitrazepam
TitleSponsorPhase
Ketogenic Diet in Infants With Epilepsy (KIWE)Alder Hey Children's NHS Foundation TrustPhase 4
Ketogenic Diet in Infants With Epilepsy (KIWE)Birmingham Children's Hospital NHS Foundation TrustPhase 4
Ketogenic Diet in Infants With Epilepsy (KIWE)Bristol Royal Hospital for ChildrenPhase 4

See all Nitrazepam clinical trials

Clinical Trial Summary for Nitrazepam

Top disease conditions for Nitrazepam
Top clinical trial sponsors for Nitrazepam

See all Nitrazepam clinical trials

US Patents for Nitrazepam

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Nitrazepam   Start Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Nitrazepam   Start Trial Methyl diazepane orexin receptor antagonists Merck Sharp & Dohme Corp. (Rahway, NJ)   Start Trial
Nitrazepam   Start Trial Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof The Regents of the University of California (Oakland, CA)   Start Trial
Nitrazepam   Start Trial Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse Acura Pharmaceuticals, Inc. (Palatine, IL)   Start Trial
Nitrazepam   Start Trial Tamper-resistant pharmaceutical compositions of opioids and other drugs COLLEGIUM PHARMACEUTICAL, INC. (Canton, MA)   Start Trial
Nitrazepam   Start Trial Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Nitrazepam

Drugname Country Document Number Estimated Expiration Related US Patent
Nitrazepam Canada 2961033 2034-09-11   Start Trial
Nitrazepam European Patent Office 3192791 2034-09-11   Start Trial
Nitrazepam Japan WO2016039408 2034-09-11   Start Trial
Nitrazepam World Intellectual Property Organization (WIPO) 2016039408 2034-09-11   Start Trial
Nitrazepam World Intellectual Property Organization (WIPO) 2016085784 2034-11-26   Start Trial
Nitrazepam European Patent Office 2981556 2033-04-02   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Moodys
Express Scripts
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.